[{"AccountsPayableCurrent_0_Q1_USD":2396000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":9006000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":5000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":1393000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":1858000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":300000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":-47000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":6634000.0,"IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_1_Q1_USD":200000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":1989000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":1393000.0,"DeferredTaxAssetsNetNoncurrent_0_Q1_USD":6370000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":13785000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":1041000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-1346000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1_Q1_USD":7425000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q1_USD":39251000.0,"AvailableForSaleSecurities_0_Q1_USD":39256000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":1184000.0,"DeferredRevenueCurrent_0_Q1_USD":4928000.0,"IncomeLossFromContinuingOperations_1_Q1_USD":148000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":1036000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":-194000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":1804000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-21355000.0,"IncomeTaxesReceivable_0_Q1_USD":561000.0,"AvailableForSaleSecuritiesCurrent_0_Q1_USD":39256000.0,"EarningsPerShareDiluted_1_Q1_USD":0.01,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":10500000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-5000.0,"PaymentsToAcquireAvailableForSaleSecurities_1_Q1_USD":21758000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":14.38,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q1_USD":200000.0,"ProvisionForDoubtfulAccounts_1_Q1_USD":-27000.0,"ContractWithCustomerAssetNet_0_Q1_USD":7847000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1_Q1_USD":23000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":22616000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q1_USD":12142000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":1964000.0,"PaymentForContingentConsiderationLiabilityOperatingActivities_1_Q1_USD":608000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_1_Q1_USD":2592000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-50000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.046,"OperatingLeaseRightOfUseAsset_0_Q1_USD":1696000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":2394000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":472000.0,"OperatingLeaseLiability_0_Q1_USD":2866000.0,"NumberOfOperatingSegments_1_Q1_Segment":2.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":2224000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":376000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":538000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":536000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":547000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_1_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_1_Q1_USD":0.0,"DeferredRevenueNoncurrent_0_Q1_USD":10907000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":1799000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_1_Q1_USD":-59000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q1_USD":30377000.0,"InvestmentIncomeNet_1_Q1_USD":250000.0,"LeaseCost_1_Q1_USD":100000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":5090000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":558000.0,"GoodwillForeignCurrencyTranslationGainLoss_1_Q1_USD":375000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":10361000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":4878000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-3112000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"StockholdersEquity_0_Q1_USD":123326000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":110853000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":30766000.0,"ProfitLoss_1_Q1_USD":148000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":91000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":4164000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":1671000.0,"NetIncomeLoss_1_Q1_USD":148000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-909000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-16004000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-4465000.0,"LiabilitiesCurrent_0_Q1_USD":14191000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":155058000.0,"Liabilities_0_Q1_USD":31732000.0,"InventoryNet_0_Q1_USD":4951000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":800000.0,"AccountsReceivableNetCurrent_0_Q1_USD":7681000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":1432000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":100000.0,"Assets_0_Q1_USD":155058000.0,"AssetsCurrent_0_Q1_USD":73466000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":9006000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.05,"CommonStockSharesIssued_0_Q1_shares":13593069.0,"CommonStockValue_0_Q1_USD":680000.0,"CostsAndExpenses_1_Q1_USD":22882000.0,"ForeignCurrencyExchangeRateTranslation1_0_Q1_EUR\/USD":1.1215,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-102000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-250000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":529000.0,"CommonStockSharesOutstanding_0_Q1_shares":13593069.0,"CommonStockSharesAuthorized_0_Q1_shares":45000000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q1_pure":0.21,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":16592000.0,"InventoryRawMaterials_0_Q1_USD":2409000.0,"InventoryWorkInProcess_0_Q1_USD":1349000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":257000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":1000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":3203000.0,"EarningsPerShareBasic_1_Q1_USD":0.01,"InventoryFinishedGoods_0_Q1_USD":1193000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q1_USD":1610000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":2279000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":2319000.0,"Goodwill_0_Q1_USD":26546000.0,"NonoperatingIncomeExpense_1_Q1_USD":164000.0,"OtherAssetsNoncurrent_0_Q1_USD":4125000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":13469000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":1668000.0,"UndistributedEarningsOfForeignSubsidiaries_0_Q1_USD":0.0,"IncreaseDecreaseInInventories_1_Q1_USD":413000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":176000.0,"IncomeTaxesPaidNet_1_Q1_USD":4000.0,"InterestExpense_1_Q1_USD":40000.0,"OperatingIncomeLoss_1_Q1_USD":-266000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.05,"PreferredStockSharesAuthorized_0_Q1_shares":450000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"AmortizationOfIntangibleAssets_1_Q1_USD":700000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":6943000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q1_pure":0.378,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.016,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":91000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":13769000.0,"PreferredStockValue_0_Q1_USD":null,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q1_USD":2700000.0,"Ticker":"SRDX","CIK":"924717","name":"SURMODICS INC","OfficialName":"Surmodics Inc. Common Stock","form":"10-Q","period":"20191231","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"609353600.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20200207"}]